Skip to main content

Divita Charles III's Form 4 filing

Teladoc Health, Inc. (TDOC) · filed Jun 3, 2026

Accession no.
0001347535-26-000006
Filed
Jun 3, 2026
Trade date
Jun 1-2, 2026
Filing delay
2 days
Rule 10b5-1 plan
Not checked

This filing lists 3 non-derivative transactions and 2 derivative transactions. Open-market sales total $146.0K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Divita Charles IIICIK 0001347535Director, Officer (CHIEF EXECUTIVE OFFICER)

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jun 1, 2026Common StockMOption exerciseAcquired+1,966––366,750Direct
Jun 1, 2026Common StockMOption exerciseAcquired+42,276––409,026Direct
Jun 2, 2026Common StockSSaleDisposed−19,132$7.63−$145,977.16389,894Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jun 1, 2026Common StockMOption exerciseDisposed−1,966$0.00$013,761Direct
Jun 1, 2026Common StockMOption exerciseDisposed−42,276$0.00$0295,939Direct

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)